VIMPAT 50 MG Oral Tablet

RxCUI: 810002
RxNorm name: VIMPAT 50 MG Oral Tablet
Display name: VIMPAT 50 MG Oral Tablet
Full name: VIMPAT 50 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:10

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Vimpat	LACOSAMIDE	UCB, Inc.	9e79b42c-38a3-4b2c-a196-a5a1948250e2	2026-05-12	Warnings, Adverse reactions	Exact identifier rxcui: 810002

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
9e79b42c-38a3-4b2c-a196-a5a1948250e2	VIMPAT 50 MG Oral Tablet [PSN] · lacosamide 50 MG Oral Tablet [Vimpat] [SBD] · Vimpat 50 MG Oral Tablet [SY]	3	63	These highlights do not include all the information needed to use VIMPAT ® safely and effectively. See full prescribing information for VIMPAT. VIMPAT ® (lacosamide) film coated tablet, for oral use, CV VIMPAT ® (lacosamide) injection, for intravenous use, CV VIMPAT ® (lacosamide) oral solution, CV Initial U.S. Approval: 2008	20260512
1310e776-65c8-413d-aab5-81a8c15719c5	VIMPAT 50 MG Oral Tablet [PSN] · lacosamide 50 MG Oral Tablet [Vimpat] [SBD] · Vimpat 50 MG Oral Tablet [SY]	3	2	These highlights do not include all the information needed to use VIMPAT ® safely and effectively. See full prescribing information for VIMPAT. VIMPAT ® (lacosamide) Tablet, Film Coated for Oral use, CV VIMPAT ® (lacosamide) Injection for Intravenous use, CV VIMPAT ® (lacosamide) Oral Solution, CV Initial U.S. Approval: 2008	20120112